 | Up a level |
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). New prospects for PCSK9 inhibition? European Heart Journal, 39(27), pp. 2600-2601. Oxford University Press 10.1093/eurheartj/ehy147
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. European Heart Journal, 39(14), pp. 1131-1143. Oxford University Press 10.1093/eurheartj/ehx549
